These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8308131)

  • 1. Comparison of three buffers used in the formulation of buffered charcoal yeast extract medium.
    Edelstein PH; Edelstein MA
    J Clin Microbiol; 1993 Dec; 31(12):3329-30. PubMed ID: 8308131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natamycin as a selective antifungal agent in media for growth of Legionella spp.
    Edelstein PH; Edelstein MA
    J Clin Microbiol; 1996 Jan; 34(1):185-7. PubMed ID: 8748300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different agars used in the formulation of buffered charcoal yeast extract medium.
    Edelstein PH; Edelstein MA
    J Clin Microbiol; 1991 Jan; 29(1):190-1. PubMed ID: 1993756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the plating efficiencies and shelf lives of three different commercial buffered charcoal yeast extract media supplemented with alpha-ketoglutaric acid.
    Edelstein PH; Edelstein MA
    J Clin Microbiol; 2010 May; 48(5):1882-3. PubMed ID: 20200292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2132-6. PubMed ID: 2619277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Holzknecht B
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2387-91. PubMed ID: 1489182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dye-containing buffered charcoal-yeast extract medium for differentiation of members of the family Legionellaceae.
    Vickers RM; Brown A; Garrity GM
    J Clin Microbiol; 1981 Feb; 13(2):380-2. PubMed ID: 7009642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aniline blue-containing buffered charcoal-yeast extract medium for presumptive identification of Legionella species.
    Holmes RL
    J Clin Microbiol; 1982 Apr; 15(4):723-4. PubMed ID: 7040468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased recovery of Legionella micdadei and Legionella bozemanii on buffered charcoal yeast extract agar supplemented with albumin.
    Morrill WE; Barbaree JM; Fields BS; Sanden GN; Martin WT
    J Clin Microbiol; 1990 Mar; 28(3):616-8. PubMed ID: 2324282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
    Pendland SL; Martin SJ; Chen C; Schreckenberger PC; Danziger LH
    J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of superoxide and hydrogen peroxide in medium used to culture Legionella pneumophila: catalytic decomposition by charcoal.
    Hoffman PS; Pine L; Bell S
    Appl Environ Microbiol; 1983 Mar; 45(3):784-91. PubMed ID: 6303219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incubation of premise plumbing water samples on Buffered Charcoal Yeast Extract agar at elevated temperature and pH selects for Legionella pneumophila.
    Veenendaal HR; Brouwer-Hanzens AJ; van der Kooij D
    Water Res; 2017 Oct; 123():439-447. PubMed ID: 28689128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of media for recovery of clinical isolates of Legionella pneumophila.
    Keathley JD; Winn WC
    Am J Clin Pathol; 1985 Apr; 83(4):498-9. PubMed ID: 3885714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Culturing, media, and handling of legionella.
    Chatfield CH; Cianciotto NP
    Methods Mol Biol; 2013; 954():151-62. PubMed ID: 23150393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila.
    Feeley JC; Gibson RJ; Gorman GW; Langford NC; Rasheed JK; Mackel DC; Baine WB
    J Clin Microbiol; 1979 Oct; 10(4):437-41. PubMed ID: 393713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of culture methods for monitoring Legionella species in hospital potable water systems and recommendations for standardization of such methods.
    Ta AC; Stout JE; Yu VL; Wagener MM
    J Clin Microbiol; 1995 Aug; 33(8):2118-23. PubMed ID: 7559959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the selective inhibition of growth of virulent Legionella pneumophila by supplemented Mueller-Hinton medium.
    Catrenich CE; Johnson W
    Infect Immun; 1989 Jun; 57(6):1862-4. PubMed ID: 2722245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and phenotypic characterization of Legionella species on semisolid media made with washed agar.
    Rogers JE; Jones GW; Engleberg NC
    J Clin Microbiol; 1993 Jan; 31(1):149-51. PubMed ID: 8417021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence conversion of Legionella pneumophila serogroup 1 by passage in guinea pigs and embryonated eggs.
    Elliott JA; Johnson W
    Infect Immun; 1982 Mar; 35(3):943-6. PubMed ID: 7068223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.